Confidence in products made by Chinese pharmaceutical firms has sunk to a new low. Photo: Reuters

How China’s protectionist vaccine policy has backfired on Beijing

Strict screening process including Chinese clinical trials has left big foreign drug makers with a tiny share of the lucrative market

Topic |   Vaccine scandal in China

TOP PICKS

Confidence in products made by Chinese pharmaceutical firms has sunk to a new low. Photo: Reuters
READ FULL ARTICLE
Orange Wang

Orange Wang

Orange Wang covers the Chinese macroeconomy, and has many years of experience with China's monetary and fiscal policy moves. He also covered global market and financial news for a long time, with a particular focus on new technologies and their influences on economic growth and society. Before joining the South China Morning Post, Orange worked as a Shanghai Correspondent for ET Net, a Hong Kong financial news agency.